Stocks Screener

Search any stock or ticker

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

How This Company Makes Money

Dividend Analysis AMBUJACEM

Max Ratio

Dividend Yield

1.12 %

5Y Dividend Growth

167.00 %

Consecutive Years

5Y Average Payout Ratio

59.22 %

Dividend History AMBUJACEM

1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021
Forward Annual Dividend Yield 1.12 %
Consecutive Years 0
Forward Annual Dividend 6.00 INR
Consistent Years 0
Dividend CAGR 3Y 58.74 %
Continuous Dividends
Dividend CAGR 5Y 21.67 %
Payout Ratio TTM 13.97 %
Dividend CAGR 10Y
Ex Dividend Date 06/13/2025

The 5 Pillars Formula Checklist

The Five-Pillar Secret Formula Checklist is our simple, proven way to separate strong, lasting businesses from the rest. We look at five key pillars—sales growth, profit growth, Net Income, dividend safety, and debt levels. Together with Financial Score, they tell us if a company can keep growing, stay financially solid, and reliably pay dividends for decades.

Sales Growth AMBUJACEM

Sales Growth – The Foundation of a Strong Business. Consistent revenue growth over the past 10-15 years is a key sign of a thriving company. It shows that demand for its products and services is increasing, allowing it to expand operations, gain market share, and invest in future growth.
1 year
3 years
5 years
10 years

Profit Growth / Profit Margin AMBUJACEM

The Fuel for Company Growth. Revenue alone isn’t enough—what truly matters is how efficiently a company turns that revenue into consistent, growing profits. Profitability is the foundation of sustainable growth and long-term financial strength.
1 year
3 years
5 years
10 years

Net Income AMBUJACEM

The True Measure of Financial Strength. Net income is what remains after all expenses, taxes, and costs. This is the company’s real earning power.
1 year
3 years
5 years
10 years

Payout Ratio TTM AMBUJACEM

Dividend Payout Safety – Protecting Your Passive Income. A high dividend yield is meaningless if the company can’t afford to sustain it. We evaluate payout ratios to ensure the company is not overextending itself. The best companies have a balanced approach—paying generous dividends while still reinvesting in future growth. Dividend safety is crucial for long-term income stability.
1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021

Debt Ratio AMBUJACEM

Debt Burden – Avoiding Financial Traps. Too much debt can cripple a company, even if its revenues and profits look great. We analyze how well a company manages its liabilities, ensuring that debt levels are under control.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021

Full Financial Performance

See how the company makes money over time—revenue, profits, dividends, and more. The charts on the right give you a quick view of growth trends so you can instantly spot consistency or red flags.

Ambuja Cements Limited AMBUJACEM

1 year
3 years
5 years
10 years
Results 2019 Dynamics
* The data for this period has not yet been published

Bottom Line

Valuation Check

Shows if a stock is priced fairly by looking at peers and the company’s own history — a quick way to see if it’s a bargain or overpriced.

Value vs Peers

The company is measured against at least 10 rivals in the same sector. If it earns 25% more profit per share than the average, it’s Undervalued. If it earns 25% less, it’s Overvalued. In short: stronger earnings per share mean you’re getting a bargain, weaker ones mean you’re overpaying.

Value vs Itself AMBUJACEM

P/E shows how many dollars investors pay in the stock price for each $1 of profit the company earns per share. Today’s P/E is compared with the company’s 10-year average. If the ratio is above that norm, you’re paying up for each dollar of profit. If it’s below, you’re getting more earnings for less.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021
Trailing PE 23.84
Forward PE 34.36
Enterprise Value Revenue 3.64
Price Sales TTM 3.50
Enterprise Value EBITDA 13.92
Price Book MRQ 2.42

Ambuja Cements Limited Dividends: 0.37 % Yield, History, Payment Schedule

AMBUJACEM
Current price
536.90 INR +1.3 INR (+0.24%)
Last closed 535.35 INR
ISIN INE079A01024
Sector Basic Materials
Industry Building Materials
Exchange National Stock Exchange of India
Capitalization 1 356 455 940 306 INR
Yield for 12 month -5.99 %
1Y
3Y
5Y
10Y
15Y
AMBUJACEM
11/21/2021 - 11/28/2021

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Advanced Highlights

Current Year

+351 743 219 665 INR

Last Year

+332 822 325 972 INR

Current Quarter

+103 271 091 254 INR

Last Quarter

+99 251 686 082 INR

Current Year

+196 566 839 202 INR

Last Year

+192 463 023 045 INR

Current Quarter

+62 746 321 324 INR

Last Quarter

+51 969 425 433 INR
EBITDA 71 012 769 461 INR
Operating Margin TTM 9.55 %
Price to Earnings 23.84
Return On Assets TTM 3.14 %
PEG Ratio
Return On Equity TTM 11.12 %
Wall Street Target Price 59 489.33 INR
Revenue TTM 387 063 529 576 INR
Book Value 228.39 INR
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 22.10 %
Dividend Yield 1.12 %
Gross Profit TTM 224 414 819 654 INR
Earnings per share 23.01 INR
Diluted Eps TTM 23.01 INR
Most Recent Quarter II 2025
Quarterly Earnings Growth YOY 286.50 %
Profit Margin 14.65 %

Technical Indicators AMBUJACEM

For 52 Weeks

455.02 INR 627.26 INR
50 Day MA 565.53 INR
Shares Short Prior Month
200 Day MA 560.55 INR
Short Ratio
Shares Short
Short Percent